Business
Press Release Aug 14 2023
Lupin Limited has informed the Exchange regarding a press release dated August 14, 2023, titled "Lupin Receives Approval from U.S. FDA for Doxycycline Hyclate Delayed-ReleaseTablets USP.".
About this update from Lupin Limited
[{"type":"text","content":" Lupin Limited has informed the Exchange regarding a press release dated August 14, 2023, titled \"Lupin Receives Approval from U.S. FDA for Doxycycline Hyclate Delayed-ReleaseTablets USP.\". View Attachment","length":356,"tagName":"div"}]